PMID: 9543205Jul 21, 1998Paper

Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression

Journal of Affective Disorders
Stuart N Seidman, J G Rabkin

Abstract

Testosterone replacement therapy is an effective treatment of some depressive symptoms in hypogonadal men, and may be an effective augmentation treatment for SSRI-refractory major depression in such men. We treated five depressed men who had low testosterone levels and had not responded to an adequate SSRI trial with 400 mg testosterone replacement biweekly for 8 weeks. Four patients underwent single-blind placebo discontinuation. Patients were assessed at baseline and biweekly thereafter using the Hamilton Depression Rating Scale (HAM-D) and the Endicott Quality of Life Enjoyment and Satisfaction Scale (Q-LES-Q). Patients' mean age was 40 years, and mean testosterone level 277 ng/dl. All had a rapid and dramatic recovery from major depression following testosterone augmentation: mean 21-item HAM-D decreased from 19.2 to 7.2 by week 2, and to 4.0 by week 8; mean Q-LES-Q increased from 45% to 68%. Three of four subjects who underwent discontinuation of testosterone under single-blind placebo treatment began to relapse. Testosterone replacement therapy may be an effective treatment of depressive symptoms in some men, and warrants further research.

References

Sep 10, 1984·Life Sciences·C T FischetteB S McEwen
Jan 1, 1995·General Hospital Psychiatry·J G RabkinG Wagner
Mar 14, 1996·The New England Journal of Medicine·C J Bagatell, W J Bremner
Sep 18, 1997·International Journal of STD & AIDS·J G RabkinG J Wagner
Dec 30, 1948·The New England Journal of Medicine·M D ALTSCHULE, K J TILLOTSON

❮ Previous
Next ❯

Citations

Mar 1, 2006·Archives of Internal Medicine·Vahakn B ShahinianJames S Goodwin
Feb 20, 2009·Aging Clinical and Experimental Research·Mario AmorePietro Tagariello
Aug 27, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Michael RitsnerJean Endicott
Sep 30, 1999·Journal of Psychiatric Research·H EhrenreichH J Kunert
Aug 2, 2003·Psychoneuroendocrinology·Marie DelhezJean-Jacques Legros
Apr 18, 2003·Medical Hypotheses·David LimRalph N Martins
Aug 5, 2005·International Journal of Impotence Research·A KshirsagarC Niederberger
Jan 6, 2006·International Journal of Impotence Research·S N Seidman
Mar 14, 2007·Cognitive Neuropsychiatry·Erno J Hermans, Jack van Honk
Jan 31, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Alvin M Matsumoto
Mar 30, 2010·Molecular Human Reproduction·L VignozziM Maggi
Jul 3, 2004·Journal of Clinical Psychopharmacology·Judith G RabkinShu Hsing Lin
Jul 25, 2009·Journal of Psychiatric Practice·Fahd Aziz ZarroufMartin Kommor
Jul 16, 2008·Journal of Clinical Psychopharmacology·Young-Hoon KoMoon-Soo Lee
May 15, 2009·Journal of Clinical Psychopharmacology·Stuart N SeidmanMark Weiser
Jan 6, 2009·Current Opinion in Psychiatry·André F CarvalhoJoão L Cavalcante
Jun 22, 2012·International Journal of Endocrinology·Mario AmoreMaurizio Pompili
Aug 27, 2009·Therapeutics and Clinical Risk Management·Nazem BassilJohn E Morley
Apr 16, 2004·Drugs & Aging·Ryan M Carnahan, Paul J Perry
Sep 26, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Yun-Tse LeeAlbert Yeung
May 10, 2011·The Medical Clinics of North America·Nazem Bassil
Aug 17, 2010·Physiology & Behavior·H Bonilla-JaimeG Vázquez-Palacios
May 26, 2010·Clinics in Geriatric Medicine·Nazem Bassil, John E Morley
Sep 23, 2009·Hormones and Behavior·Gen KanayamaHarrison G Pope
Jan 27, 1999·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·S N Seidman, B T Walsh
Jan 1, 2008·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Antonio Becerra FernándezUNKNOWN En Representación Del Grupo De Trabajo De La Seen Endocrinología De La Sexualidad
Nov 7, 2007·The Urologic Clinics of North America·Antoine MakhloufCraig S Niederberger
May 21, 2003·International Journal of Andrology·Kati HärkönenPasi Pöllänen
Mar 19, 2016·Frontiers in Neuroendocrinology·Rand MahmoudLiisa A M Galea
Aug 11, 2004·Pharmacology, Biochemistry, and Behavior·Lucía Martínez-Mota, Alonso Fernández-Guasti
Apr 8, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Jean EndicottChristopher Wohlberg
Aug 30, 2001·Hematology/oncology Clinics of North America·M R Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.